Abiratas Tablet
Abiratas 250mg Tablets (Abiraterone Acetate) available in Phoenix USA Phoenix, Houston, Chicago, Los Angeles, New York City, Canada Toronto, Vancouver, Montreal, Regional Focus, North & South USA, Israel Jerusalem, for prostate cancer therapy. Reliable oncology medicine supplier for hospitals and distributors across the USA.
Category: Prescription Drug
Synonym: Abiraterone Acetate
Composition: Abiraterone β 250mg
Consume Type: Oral
About Abiratas Tablet
Abiratas Tablet belongs to a class of medicines known as androgen biosynthesis inhibitors, primarily indicated for the treatment of prostate cancer in adult men. It is used in combination with prednisone or prednisolone to manage prostate cancer that has spread to other parts of the body (metastatic disease).
The active ingredient, Abiraterone, works by inhibiting the enzyme CYP17, responsible for producing androgens (male hormones such as testosterone). Since prostate cancer cells rely on androgens for growth, lowering their levels helps slow or stop the progression of the disease.
@ERNESTPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
π§ Email: exports@ernestpharmaceuticals.com
π www.ernestpharmaceuticals.com| www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
π² WhatsApp: βͺβͺ+91 94054 76170β¬β¬
Uses of Abiratas Tablet
Treatment of advanced or metastatic prostate cancer in adult men.
Helps reduce androgen (testosterone) production, which fuels cancer cell growth.
Used with corticosteroids (prednisone/prednisolone) to improve treatment response and reduce complications.
Supports the management of castration-resistant (CRPC) and castration-sensitive prostate cancer (CSPC).
π Why Choose Ernest Pharmaceutical Pvt. Ltd.
π ISO Certified Exporter
π 10+ Years of Global Pharma Export Experience
π Private Label & OEM Supply Options
π Complete Regulatory Documentation (COA, COPP, COO, )
π Temperature-Controlled International Logistics via DHL, FedEx & Aramex
Medicinal Benefits
Slows disease progression by cutting off the hormone supply that promotes cancer growth.
Improves survival outcomes in patients with advanced prostate cancer.
Often prescribed with androgen deprivation therapy (ADT) for comprehensive hormonal control.
Demonstrates efficacy both in patients who have and have not received prior chemotherapy.
Directions for Use
Take Abiratas Tablet on an empty stomach β at least 1 hour before or 2 hours after meals.
Swallow the tablet whole with a glass of water; do not chew, crush, or break it.
Follow your doctorβs exact dosage instructions for optimal effectiveness.
Possible Side Effects
Common side effects may include:
Swelling of joints or legs (edema)
Fatigue or weakness
High blood pressure
Low potassium levels
Muscle pain
Indigestion or nausea
Urinary tract infection
Discomfort or frequent urination
If any of these symptoms persist or worsen, consult your healthcare provider promptly.
π³ Payment & Logistics
π± Accepted Payment Modes: TT (Telegraphic Transfer), LC, PayPal, Bank Transfer
π Contact for Bulk Orders & Price Quotations
Ernest Pharmaceutical Pvt. Ltd.
π§ Email: exports@ernestpharmaceuticals.com
Safety Information & Precautions
Not intended for use in women, children, or adolescents.
Avoid use with Ra-233 (Radium-223 dichloride) due to an increased risk of bone fracture or death.
Use caution if you have liver disease, heart conditions, or electrolyte imbalances.
Regular monitoring of liver function, blood pressure, and potassium levels is advised during therapy.
Do not exceed the prescribed dose. In case of accidental overdose, seek immediate medical assistance.
Storage Instructions
Store in a cool, dry place away from direct sunlight.
Maintain at 10Β°C to 25Β°C, not exceeding 30Β°C.
Keep out of reach of children.
How Abiratas Tablet Works
Abiratas Tablet contains Abiraterone, which inhibits the enzyme CYP17, a critical component in testosterone synthesis. By blocking testosterone production, it deprives prostate cancer cells of the hormones they need to grow, effectively controlling disease progression.